NCT03857009

Brief Summary

Full-thickness rotator cuff tears (FTRCT), defined as "through-and-through" tears of one of the shoulder tendons, affect up to 32% of the population (mostly individuals older than 50 years) and are one of the most painful and debilitating shoulder diagnoses. One of the primary challenges for clinical decision-making is the poor association between the presence of FTRCT (detected by medical imaging) and pain, as studies have shown that 2/3 of people with FTRCT are asymptomatic. This challenges the notion that FTRCT causes pain, and highlights the fact that symptoms may be explained by other variables. A better understanding of the factors leading to the development of pain in people with FTRCT would optimize clinical care (including prevention). The objective of this study is to identify variables associated with pain in people with FTRCT by 1) comparing people with FTRCT with (Symptomatic Group; n=40) and without pain (Asymptomatic Group; n=40); 2) comparing people who initially have pain-free FTRCT (Asymptomatic Group) who develop pain over a 2-year period to those who do not develop pain; and 3) comparing people who initially have painful FTRCT (Symptomatic Group) who become pain-free over a 2-year period to those who remain symptomatic. All participants will undergo an ultrasound examination to confirm the presence of FTRCT, and information on a number of variables (sociodemographic, anatomical, genetic, psychosocial, pain sensitivity, neuromuscular, biomechanical) will be collected. All participants will then be followed for 2 years before being revaluated for pain. Variables will be analysed to determine those associated with pain. As it is crucial to improve our understanding of the mechanisms leading to pain, this project has the potential to impact the musculoskeletal health of Canadians. By considering multiple variables associated with FTRCT, its results could lead to the development of tangible solutions to optimize prevention and recovery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
260

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 5, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 9, 2018

Completed
7 months until next milestone

First Posted

Study publicly available on registry

February 27, 2019

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
Last Updated

February 20, 2020

Status Verified

February 1, 2020

Enrollment Period

3.6 years

First QC Date

August 9, 2018

Last Update Submit

February 19, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in usual shoulder pain from baseline: Visual analog scale (VAS)

    Participants will be asked to rate the intensity of their pain on a VAS from 0 to 10, where "0" represents no pain and "10" represents "worst pain imaginable", in the last week, month and 3 months. Highest possible score (worst outcome): 30. Lowest possible score (best outcome): 0. Method to compute total score: sum of each score.

    From baseline to the follow-up evaluation (end of the 2-year period) (Objective 2 and 3)

  • usual shoulder pain from baseline: Visual analog scale (VAS)

    Participants will be asked to rate the intensity of their pain on a VAS from 0 to 10,

    Baseline score (Objective 1)

Secondary Outcomes (38)

  • Change from baseline with regard to: Sociodemographic and occupational factors

    From baseline to the follow-up evaluation (end of the 2-year period)(Objective 2 and 3)

  • Sociodemographic and occupational factors

    Baseline characteristics (Objective 1)

  • Change in disability and functional limitations of the upper extremity from baseline: QuickDASH

    From baseline to the follow-up evaluation (end of the 2-year period)(Objective 2 and 3)

  • Disability and functional limitations of the upper extremity QuickDASH

    Baseline score (Objective 1)

  • Change in comorbidities from baseline: Self-Administered Comorbidity Questionnaire

    From baseline to the follow-up evaluation (end of the 2-year period)(Objective 2 and 3)

  • +33 more secondary outcomes

Study Arms (2)

Symptomatic

No intervention.

Asymptomatic

No intervention.

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults aged 50 to 80 years presenting with symptomatic or asymptomatic full-thickness rotator cuff tears.

You may qualify if:

  • Presence of a full-thickness rotator cuff tear (on ultrasound examination performed by a radiologist)
  • to 80 years of age
  • Degenerative tear (no significant trauma)
  • unilateral or bilateral shoulder pain (at least 2/10 on a visual analog scale \[VAS\] evaluating usual shoulder pain)
  • positive response to: 'In the past 4 weeks, have you had pain in your shoulder' and 'If yes, was this pain bad enough to limit your usual activities or change your daily routine for more than 1 day?'
  • report no current shoulder pain (0/10 on a VAS evaluating usual shoulder pain)
  • negative response to: 'In the past 4 weeks, have you had pain in your shoulder'
  • do not report any past significant shoulder pain (any pain greater than or equal to 2/10 that lasted longer than 4 weeks, required the use of medications or prompted a physician visit)

You may not qualify if:

  • unable to understand French or English;
  • history of upper limb fracture;
  • previous shoulder surgery;
  • cervicobrachialgia or shoulder pain reproduced by neck movement;
  • shoulder capsulitis (restriction of at least 30% in 2 or more directions);
  • rheumatoid, inflammatory or neurological diseases;
  • corticosteroid injection in the previous 6 weeks;
  • cognitive problems interfering with evaluations (Mini-Mental State Examination ≥ 24)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS)

Québec, Quebec, Canada

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

DNA (saliva) samples will be collected at the baseline evaluation only. The samples will be analyzed for pain modulatory genes.

Study Officials

  • Jean-Sébastien Roy, PT, PhD

    Laval University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jean-Sébastien Roy, PT, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Faculty of Medicine

Study Record Dates

First Submitted

August 9, 2018

First Posted

February 27, 2019

Study Start

June 5, 2018

Primary Completion

December 30, 2021

Study Completion

December 30, 2021

Last Updated

February 20, 2020

Record last verified: 2020-02

Locations